ArticleCancer biomarkers : section A of Disease markers2023

CHRDL1, NEFH, TAGLN and SYNM as novel diagnostic biomarkers of benign prostatic hyperplasia and prostate cancer.

Zhiyong Su et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.